摘要
大环内酯类抗生素是以多羟基14-16元大环内酯为母体,通过内酯环上的羟基和去氧氨基糖缩合而成的碱性苷化合物。1952年,第一个大环内酯类抗生素红霉素(Erythro-mycin,图1)被发现,但由于其化学性质不稳定,
出处
《中兽医医药杂志》
2012年第2期24-29,共6页
Journal of Traditional Chinese Veterinary Medicine
基金
"十二五"农村领域国家科技计划
参考文献20
-
1姚晓英,张永信.大环内酯类抗生素的发展和研究近况[J].上海医药,2011,32(7):319-322. 被引量:15
-
2Xu P,Liu L,Lei P S,et al.Synthesis of novel macrolidederivatives with imidazo[4,5-b]pyridinyl sulfur containedalkyl side chains and their antibacterial activity[J].Journal ofBioorganic&Medicinal Chemistry Letters,2009,19(15):4079-4083.
-
3Putnam S D,Castanheira M,Moet G J,et al.CEM-101,anovel fluoroketolid:antimicrobial activity against a diversecollection of gram-positive and gram-negative bacteria[J].Diagnostic Microbiology and Infectious Disease,2010,66(4):303-401.
-
4Magee T V,Ripp S L,Li B,et al.Discovery of AzetidinylKetolides for the treatment of susceptible and multidrugesistant[J].Journal of Medicinal Chemistry,2009,52(23):7446-7457.
-
5Baker W R,Clark J D,Stephens R L,et al.Modification ofmacrolide antibiotics.Synthesis of 11-deoxy-11-(carboxyamino)-6-O-methylerythromycin A 11,12-(cyclicesters)via an intramolecular michael reaction of O-carbamates an alphabeta-unsaturated ketone[J].Journal ofOrganic Chemistry,1998,53(10):2340-2345.
-
6Douthwaitc S.Structure activity relationships of ketolides vs.macrolides[J].Clinical Microbiology and Infection,2001,7(s3):11-17.
-
7Bryskier A.Ketolides-telithromycin,an example of a newclass of antibacterial agents[J].Clin Microbial Infect,2000,6(12):661-669.
-
8Low D E,Felmingham D,Brown S D,et al.Activity oftelithromycin against key pathogens associated withcommunity-acquired respiratory tract infections[J].Journal ofInfection,2004,49(2):115-125.
-
9Takashi N,Tatsuro Y,Yukitoshi N,et al.9-Oxime-3-ketolides:Modification at the C-11,12-diol moiety andantibacterial activities against key respiratory pathogens[J].Journal of Bioorganic&Medicinal Chemistry,2005,13(21):6054-6063.
-
10Takashi N,Iwaki T,Narukawa Y,et al.A new type ofketolide bearing an N-aryl-alkyl acetamide moiety at theC-9 iminoether:Synthesis and structure activity relatio-nships(2)[J].Journal of Bioorganic&Medicinal Chemistry,2006,14(11):3697-3711.
二级参考文献14
-
1王登旭,王二兵,彭向前.泰利霉素的药理作用及临床应用[J].中国药物与临床,2005,5(7):524-525. 被引量:7
-
2Farrell DJ, Sader HS, Castanheira M, et al. Antimicrobial characterisation of CEM-IO1 activity against respiratory tract pathogens, including muhidrug-resistant pneumocoecal serogroup 19A isolates [ J ]. In J Antimicrob Agents, 2010, 35(6~: 537-5d3_.
-
3刘剑,杨明.泰利霉素研究进展[C]//四川省生理科学学会第八届学术交流会暨西部地区生理学学术研讨会.四川省生理科学学会第八届学术交流会暨西部地区生理学学术研讨会论文集.四川宜宾:[出版者不详],2007:87-89.
-
4Rospide MF, Biedenbach D J, Jones RN. Comparative antimicrobial activity of ABT-773, a novel ketolide, tested against drug-resistant Gram-positive cocci and Haemophilus intIuenzae [ J ]. In J Antimicrob Agents, 2001, 17(6): 451- 455.
-
5Johnson CN, Benjamin WH Jr, Gray BM, et al. In vitro activity of ABT-773, telithromyein and eight other antimierobials against erythromyein-resistant Streptococcus pneumoniae respiratory isolates of children [ J ]. In J Antimierob Agents, 2001, 18(6): 531-535.
-
6Putnam SD, Sader HS, Farrell D J, et al. Antimicrobial eharaeterisation of solithromyein (CEM-101), a novel fluoroketolide: activity against staphylococci and enterocoeei [ J ]. In J Antimicrob Agents, 2011, 37(1): 39-45.
-
7Putnam SD, Castanheira M, Moet GJ, et al. CEM-101, a novel fluoroketolide : Antimicrobial activity against a diverse collection of Gram-positive and Gram-negative bacteria [ J ].Diagn Microb Inlet Dis, 2010, 66(4): 393-401.
-
8Farrell D J, Castanheira M, Sader HS, et al. The in vitro evaluation of solithromycin (CEM-101) against pathogens isolated in the United States and Europe (2009) [ J ]. J Infec, 2010, 61(6): 476-483.
-
9Jiang LJ, Or YS. Pharmacokineyics of EDP-420 after muhiple oral doses in healthy aduh vohmteers and in a bioequivalenee study[J].Antimicrob Agents Chemother, 2009, 53(8): 3218-3225.
-
10徐林,俞雄,朱宝泉.酮内酯类抗生素的研究进展[J].中国医药工业杂志,2009,40(8):627-636. 被引量:3
共引文献14
-
1王国威.低剂量克拉霉素治疗慢性咽炎临床分析[J].医学信息(医学与计算机应用),2014,0(30):240-240.
-
2耿新宇.低剂量克拉霉素与头孢呋辛片治疗咽炎的临床对照研究[J].中国医学工程,2011,19(10):35-35. 被引量:1
-
3郭强,马淑涛.大环内酯类抗生素糖基的结构修饰[J].中国抗生素杂志,2013,38(1):12-21. 被引量:8
-
4居宇峰,刘青青,王智鹏.2010—2012年南通市第三人民医院抗菌药物应用分析[J].中国医院用药评价与分析,2013,13(9):794-797. 被引量:2
-
5孙俊,王展,张为革.抗菌活性红霉素衍生物研究进展[J].沈阳药科大学学报,2014,31(6):493-504. 被引量:4
-
6徐中良,金梅.2010~2013年重庆医科大学附属永川医院抗菌药物调查分析[J].重庆医学,2014,43(23):3051-3054. 被引量:4
-
7史大昕,冯雪,庄晓磊,柴洪新,刘霆,张奇,李加荣.一类新型大环内酯衍生物的合成及其生物活性研究[J].有机化学,2014,34(12):2543-2550.
-
8赵娜,毕小玲.6-O-取代红霉素衍生物的研究进展[J].药学进展,2015,39(3):179-187. 被引量:1
-
9邵莉萍,张继瑜.酮内酯类抗生素的研究进展[J].黑龙江畜牧兽医,2017(4):78-83. 被引量:3
-
10吕磊,廖华媛,余兴龙.PRRSV蛋白抑制IFN-Ⅰ产生及抗病毒功能的作用机制[J].黑龙江畜牧兽医,2017(7):72-75.
同被引文献7
-
1Flamm R K. The new antibacterial class: The ketolides[J]. Clin MicrobiolNewslett, 2000, 22(17): 129-133.
-
2Rospide M F, Biedenbach D J, Jones R N. Comparative antimicrobial activity of ABT-773, a novel ketolide, tested against drug-resistant Gram-positive cocci and Haemophilus influenzae[J]. Int J Antimicrob Agents, 2001, 17(6), 451-455.
-
3姚晓英,张永信.大环内酯类抗生素的发展和研究近况[J].上海医药,2011,32(7):319-322. 被引量:15
-
4李喆宇,崔玉彬,张静霞,唐克慧.大环内酯类抗生素的研究新进展[J].国外医药(抗生素分册),2013,34(1):6-15. 被引量:36
-
5Ying Nie,Yin Sun,Qi-Dong You.Synthesis and antibacterial activity of novel 10,11-epoxy acylide erythromycin derivatives[J].Chinese Chemical Letters,2013,24(3):183-185. 被引量:1
-
6孙俊,王展,张为革.抗菌活性红霉素衍生物研究进展[J].沈阳药科大学学报,2014,31(6):493-504. 被引量:4
-
7张建民,杨秀珍.ABT-773的合成、药效学及药物动力学[J].国外医药(抗生素分册),2002,23(6):261-266. 被引量:2
-
1张国红.兽医抗感染药物的合理应用(三)——氨基糖苷类药物的合理应用[J].兽医导刊,2004,0(4):24-25.
-
2薛强.抗生素在国外畜禽饲料中的使用[J].畜牧兽医科技信息,2017,33(5):132-133. 被引量:1
-
3邵莉萍,张继瑜.酮内酯类抗生素的研究进展[J].黑龙江畜牧兽医,2017(4):78-83. 被引量:3
-
4阎祥洲,刘升伟,丁升艳.谷氨酰胺的生理功能及在动物营养中的应用[J].浙江畜牧兽医,2003,28(4):10-11. 被引量:2
-
5秦生巨.噬菌蛭弧菌分子生物学特性的研究(七)[J].当代水产,2015,40(12):72-72.
-
6刘明美,吕宗友,戎婧.谷氨酰胺在鸡营养中的研究进展[J].家禽科学,2011(1):47-50.
-
7陈鲜花,张健騑,郭世宁,谭滇湘,陈志虹,尹烨华,王刚.氨基糖甙类药物对广东鸡致病性大肠杆菌敏感性调查[J].广东畜牧兽医科技,2005,30(3):39-40. 被引量:3
-
8刘明美,吕宗友.谷氨酰胺在猪营养中的研究进展[J].饲料与畜牧(规模养猪),2011(4):6-9.
-
9周勤华,张毅,杨胜利.一种新的卡那霉素残留检测方法[J].中国生物工程杂志,2005,25(3):84-90. 被引量:5
-
10尤康春,王茂法.犬丁胺卡那引起肌无力诊治一例[J].浙江畜牧兽医,2005,30(3):36-36.